Welcome to our dedicated page for Xiao-I Corporation news (Ticker: AIXI), a resource for investors and traders seeking the latest updates and insights on Xiao-I Corporation stock.
Xiao-I Corporation (NASDAQ: AIXI) provides investors and technology stakeholders with centralized access to official updates from this leading cognitive intelligence innovator. Track critical developments across the company's AI solutions for finance, healthcare, manufacturing, and public sector applications through verified press releases and financial disclosures.
This resource consolidates Xiao-I's strategic announcements including product launches, quarterly financial results, technology partnerships, and intellectual property developments. Users gain efficient access to updates about the company's AI-powered smart devices, HuaZang LLM framework advancements, and cloud-based Model-as-a-Service (MaaS) offerings.
All content undergoes strict verification to ensure compliance with financial disclosure standards. Bookmark this page for reliable updates on Xiao-I's progress in natural language processing, hyper-automation solutions, and cross-industry AI implementations that drive operational efficiency.
Xiao-I (NASDAQ: AIXI) announces the upcoming launch of DIF (Daily Invest Focus) in May 2024, aimed at revolutionizing stock market analysis. DIF utilizes an advanced artificial intelligence framework, Agentic Workflow, to provide investors with valuable insights for strategic decision-making. This innovative product marks a significant shift in investment strategy, empowering users with AI-driven market intelligence.
Xiao-I , a leading AI enterprise, reported a 22.8% increase in net revenues to US$59.2 million for 2023. The MaaS business grew by 48.5% and accounted for over 30% of total revenue. Gross margin rose to 66.6%, up 270 basis points year over year. The company introduced the Hua Zang Universal Large Language Model, expanded globally, and launched innovative solutions, showcasing significant growth in both MaaS and non-MaaS segments.